Not everyone responds to GLP-1 medications the same way — and true non-response, while real, is less common than people assume when results are slow to arrive.
What "non-response" actually means
There's no single universal definition, but clinically it generally refers to little to no meaningful weight loss after reaching an adequate dose and staying on it long enough for the medication to work. A slow start or a frustrating plateau isn't the same thing as non-response.
How common is it?
A meaningful minority of people on Wegovy, Zepbound, or Saxenda see limited results. Most people do lose weight on these medications — though how much varies considerably from person to person. Saxenda tends to produce more modest results on average than the newer GLP-1/GIP combinations like Zepbound.
Factors that can look like non-response but aren't:
When it might be genuine non-response:
If you've been at your target dose for several months with no meaningful change, that's worth a real conversation. Your provider may consider switching medications, investigating underlying factors, or reassessing your approach.
**Talk to your provider** before concluding a medication isn't working — what feels like failure is often a fixable variable.
Different ways people phrase this question. Each expands to the same answer.
Not everyone responds to GLP-1 medications the same way — and true non-response, while real, is less common than people assume when results are slow to arrive.
What "non-response" actually means
There's no single universal definition, but clinically it generally refers to little to no meaningful weight loss after reaching an adequate dose and staying on it long enough for the medication to work. A slow start or a frustrating plateau isn't the same thing as non-response.
How common is it?
A meaningful minority of people on Wegovy, Zepbound, or Saxenda see limited results. Most people do lose weight on these medications — though how much varies considerably from person to person. Saxenda tends to produce more modest results on average than the newer GLP-1/GIP combinations like Zepbound.
Factors that can look like non-response but aren't:
When it might be genuine non-response:
If you've been at your target dose for several months with no meaningful change, that's worth a real conversation. Your provider may consider switching medications, investigating underlying factors, or reassessing your approach.
**Talk to your provider** before concluding a medication isn't working — what feels like failure is often a fixable variable.
Not everyone responds to GLP-1 medications the same way — and true non-response, while real, is less common than people assume when results are slow to arrive.
What "non-response" actually means
There's no single universal definition, but clinically it generally refers to little to no meaningful weight loss after reaching an adequate dose and staying on it long enough for the medication to work. A slow start or a frustrating plateau isn't the same thing as non-response.
How common is it?
A meaningful minority of people on Wegovy, Zepbound, or Saxenda see limited results. Most people do lose weight on these medications — though how much varies considerably from person to person. Saxenda tends to produce more modest results on average than the newer GLP-1/GIP combinations like Zepbound.
Factors that can look like non-response but aren't:
When it might be genuine non-response:
If you've been at your target dose for several months with no meaningful change, that's worth a real conversation. Your provider may consider switching medications, investigating underlying factors, or reassessing your approach.
**Talk to your provider** before concluding a medication isn't working — what feels like failure is often a fixable variable.
Not everyone responds to GLP-1 medications the same way — and true non-response, while real, is less common than people assume when results are slow to arrive.
What "non-response" actually means
There's no single universal definition, but clinically it generally refers to little to no meaningful weight loss after reaching an adequate dose and staying on it long enough for the medication to work. A slow start or a frustrating plateau isn't the same thing as non-response.
How common is it?
A meaningful minority of people on Wegovy, Zepbound, or Saxenda see limited results. Most people do lose weight on these medications — though how much varies considerably from person to person. Saxenda tends to produce more modest results on average than the newer GLP-1/GIP combinations like Zepbound.
Factors that can look like non-response but aren't:
When it might be genuine non-response:
If you've been at your target dose for several months with no meaningful change, that's worth a real conversation. Your provider may consider switching medications, investigating underlying factors, or reassessing your approach.
**Talk to your provider** before concluding a medication isn't working — what feels like failure is often a fixable variable.